Medical Review data Study Description The primary objective of CLN01 was to determine the pharmacokinetics (PK) of intravenous (IV) clindamycin in overweight and obese children and adolescents. This s
Aim: Characterize the pharmacokinetics (PK) of ampicillin administered to children per standard of care to address gap in pediatric labeling. Methods: The PK and safety analyses include ampicillin dat
Abbreviation: Cmax, maximum concentration; Tmax, time to maximum concentration; AUC0–24 h, area under the curve from 0 to 24 h; T1/2, half-life at the elimination phase; CL, clearance; Vz, volume of d
